Support for health and well-being that extends beyond medication

Health and well-being solutions that exceed conventional medication

WELCOME TO YOUR PPF SUPPORT SPACE

Health and well-being support that goes beyond the pills

 

This space is here to support people, like you, who are living with PPF and being treated with OFEV®. We understand that being diagnosed with PPF can be difficult. This is a place to visit when you are feeling uncertain about your illness, your treatment and your care, or if you should wish to find out more about your illness and the support available to you.

This website is designed to help people like you manage your illness and associated treatments. It contains advice and materials to support you; from understanding PPF to managing your therapy with OFEV®, and how to get the most out of your interactions with your healthcare providers on how to manage expectations with loved ones.

As you tour this support space for PPF, you will see various locations that focus on specific aspects of your condition – roll over the icons to see more about these areas.

Information 'I'  icon, representing the Information Centre, within the PPF support space Information 'I'  icon, representing the Information Centre, within the PPF support space
Park Bench icon, representing the Park Bench: Holistic care area, within the PPF support space Park Bench icon, representing the Park Bench: Holistic care area, within the PPF support space
Person stretching icon with arm over their head, representing the exercise and fitness section within the page Person stretching icon with arm over their head, representing the exercise and fitness section within the page
Lotus flower icon, representing the Zen Garden: Well-being and mental health area, within the PPF support space Lotus flower icon, representing the Zen Garden: Well-being and mental health area, within the PPF support space
Picnic Bench icon, representing the Picnic Area: Diet and nutrition information, within the PPF support space Picnic Bench icon, representing the Picnic Area: Diet and nutrition information, within the PPF support space

NP-GB-103027 | July 2024

If you live in the UK and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the yellow card scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you live in the Republic of Ireland and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Health Products Regulatory Authority at www.hpra.ie or by email to medsafety@hpra.ie. By reporting side effects, you can help provide more information on the safety of this medicine.

 

THIS WEBSITE HAS BEEN DEVELOPED BY BOEHRINGER INGELHEIM AND IS INTENDED FOR PEOPLE WITH PROGRESSIVE PULMONARY FIBROSIS WHO HAVE BEEN PRESCRIBED OFEV® (NINTEDANIB).

This website is intended for people with progressive pulmonary fibrosis who have been prescribed treatment with OFEV® (nintedanib). OFEV® is used to treat idiopathic pulmonary fibrosis (IPF), or other chronic fibrosing interstitial lung diseases (ILDs) that are showing signs of progression and these diseases are referred to on this website collectively as ‘progressive pulmonary fibrosis’ (PPF).

This website aims to provide you with information about your disease and how to manage your symptoms or the side effects of your treatment, as well as to give you details on holistic support available. 

The information on this website has been developed to enhance, but not replace, the advice and help of your medical team. If you have any questions after reading this website, or any further concerns, always talk to your medical team – i.e., a nurse, doctor or pharmacist – they are here to help you. 

You’ll also find more information about OFEV® in your Patient Information Leaflet (PIL), included with your OFEV® medication pack, or on https://www.medicines.org.uk/emc/files/pil.7705.pdf if you live in Great Britain, or on https://www.emcmedicines.com/en-gb/northernireland/medicine?id=1c9c7bb7-cac4-4c5f-a633-a8220c0a16dd&type=pil if you live in Northern Ireland or on https://www.medicines.ie/medicines/ofev-150-mg-soft-capsules-33198/patient-info if you live in the Republic of Ireland.

Access your progressive pulmonary fibrosis

Pulmonary fibrosis (PPF) support space

Access your progressive pulmonary fibrosis (PPF) support space

You have been directed here by your medical team because you have been prescribed OFEV® (nintedanib).

Please provide the password given to you by your medical team to access this space:

If you are unsure of your password, please contact the medical team that prescribed you OFEV® for more information.

Required.

THE INFORMATION ON THE FOLLOWING WEB PAGES IS SUITABLE AND ONLY INTENDED FOR PEOPLE LIVING IN THE UK AND IRELAND WHO HAVE BEEN PRESCRIBED OFEV®.

BY INPUTTING THE PASSWORD, YOU ARE CONFIRMING THAT YOU ARE A PATIENT PRESCRIBED THIS MEDICINE.

If you live in the UK and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the yellow card scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you live in the Republic of Ireland and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Health Products Regulatory Authority at www.hpra.ie or by email to medsafety@hpra.ie. By reporting side effects, you can help provide more information on the safety of this medicine.

THIS WEBSITE HAS BEEN DEVELOPED BY BOEHRINGER INGELHEIM AND IS INTENDED FOR PEOPLE WITH PROGRESSIVE PULMONARY FIBROSIS WHO HAVE BEEN PRESCRIBED OFEV® (NINTEDANIB).

This website is intended for people with progressive pulmonary fibrosis who have been prescribed treatment with OFEV® (nintedanib). OFEV® is used to treat idiopathic pulmonary fibrosis (IPF), or other chronic fibrosing interstitial lung diseases (ILDs) that are showing signs of progression and these diseases are referred to on this website collectively as ‘progressive pulmonary fibrosis’ (PPF).

This website aims to provide you with information about your disease and how to manage your symptoms or the side effects of your treatment, as well as to give you details on holistic support available.

The information on this website has been developed to enhance, but not replace, the advice and help of your medical team. If you have any questions after reading this website, or any further concerns, always talk to your medical team – i.e., a nurse, doctor or pharmacist – they are here to help you. 

You’ll also find more information about OFEV® in your Patient Information Leaflet (PIL), included with your OFEV® medication pack, or on https://www.medicines.org.uk/emc/files/pil.7705.pdf if you live in Great Britain, or on https://www.emcmedicines.com/en-gb/northernireland/medicine?id=1c9c7bb7-cac4-4c5f-a633-a8220c0a16dd&type=pil if you live in Northern Ireland or on https://www.medicines.ie/medicines/ofev-150-mg-soft-capsules-33198/patient-info if you live in the Republic of Ireland.

PPF support space

pulmonary fibrosis support space

Access your progressive pulmonary fibrosis (PPF) support space

This website is intended for people with progressive pulmonary fibrosis who have been prescribed treatment with OFEV® (nintedanib). OFEV® is used to treat idiopathic pulmonary fibrosis (IPF), or other chronic fibrosing interstitial lung diseases (ILDs) that are showing signs of progression and these diseases are referred to on this website collectively as “progressive pulmonary fibrosis” (PPF).  

This website aims to provide you with information about your disease and how to manage your symptoms or the side effects of your treatment, as well as to give you details on holistic support available. 

The information on this website has been developed to enhance, but not replace, the advice and help of your medical team. If you have any questions after reading this website, or any further concerns, always talk to your medical team i.e., a nurse, doctor or pharmacist – they are here to help you. 

You’ll also find more information about OFEV® in your Patient Information Leaflet (PIL), included with your OFEV® medication pack, or on https://www.medicines.org.uk/emc/files/pil.7705.pdf if you live in Great Britain, or on https://www.emcmedicines.com/en-gb/northernireland/medicine?id=1c9c7bb7-cac4-4c5f-a633-a8220c0a16dd&type=pil if you live in Northern Ireland or on https://www.medicines.ie/medicines/ofev-150-mg-soft-capsules-33198/patient-info if you live in the Republic of Ireland.

If you live in the UK and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the yellow card scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you live in the Republic of Ireland and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Health Products Regulatory Authority at www.hpra.ie or by email to medsafety@hpra.ie. By reporting side effects, you can help provide more information on the safety of this medicine.

THIS WEBSITE HAS BEEN DEVELOPED BY BOEHRINGER INGELHEIM AND IS INTENDED FOR PEOPLE WITH PROGRESSIVE PULMONARY FIBROSIS WHO HAVE BEEN PRESCRIBED OFEV® (NINTEDANIB).

This website is intended for people with progressive pulmonary fibrosis who have been prescribed treatment with OFEV® (nintedanib). OFEV® is used to treat idiopathic pulmonary fibrosis (IPF), or other chronic fibrosing interstitial lung diseases (ILDs) that are showing signs of progression and these diseases are referred to on this website collectively as ‘progressive pulmonary fibrosis’ (PPF).

This website aims to provide you with information about your disease and how to manage your symptoms or the side effects of your treatment, as well as to give you details on holistic support available.

The information on this website has been developed to enhance, but not replace, the advice and help of your medical team. If you have any questions after reading this website, or any further concerns, always talk to your medical team – i.e., a nurse, doctor or pharmacist – they are here to help you. 

You’ll also find more information about OFEV® in your Patient Information Leaflet (PIL), included with your OFEV® medication pack, or on https://www.medicines.org.uk/emc/files/pil.7705.pdf if you live in Great Britain, or on https://www.emcmedicines.com/en-gb/northernireland/medicine?id=1c9c7bb7-cac4-4c5f-a633-a8220c0a16dd&type=pil if you live in Northern Ireland or on https://www.medicines.ie/medicines/ofev-150-mg-soft-capsules-33198/patient-info if you live in the Republic of Ireland.


NP-GB-103027 | July 2024